previously untreated childhood rhabdomyosarcoma
Showing 1 - 25 of >10,000
Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma Trial in Worldwide
Completed
- Adult Rhabdomyosarcoma
- +3 more
- conventional surgery
- +4 more
-
Birmingham, Alabama
- +162 more
Nov 17, 2021
Sarcoma Trial in New York (biological, drug, procedure, radiation)
Active, not recruiting
- Sarcoma
- filgrastim
- +10 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Nov 5, 2021
Kidney Cancer, Leukemia, Lymphoma Trial in United States (glutamic acid, )
Completed
- Kidney Cancer
- +5 more
- glutamic acid
- placebo
-
Fort Myers, Florida
- +5 more
Jul 22, 2021
Adult Malignant Mesenchymoma, Adult Rhabdomyosarcoma, Childhood Alveolar Rhabdomyosarcoma Trial in Worldwide (drug, biological,
Active, not recruiting
- Adult Malignant Mesenchymoma
- +10 more
- Irinotecan Hydrochloride
- +6 more
-
Birmingham, Alabama
- +211 more
Dec 9, 2021
Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (genetic, other, radiation)
Active, not recruiting
- Brain and Central Nervous System Tumors
- +9 more
- DNA analysis
- +4 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 28, 2021
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +23 more
- treosulfan
- +7 more
-
Denver, Colorado
- +2 more
Jun 17, 2021
Uveal Melanoma Trial in Pittsburgh (Tebentafusp)
Not yet recruiting
- Uveal Melanoma
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Oct 5, 2023
Follicular Lymphoma, Tumor Trial in Houston (Obinutuzumab, CC-99282)
Not yet recruiting
- Follicular Lymphoma
- Tumor
-
Houston, TexasM D Anderson Cancer Center
Oct 30, 2023
Obinutuzumab-based Therapy for Previously Untreated FL
Recruiting
- Follicular Lymphoma
- Obinutuzumab
- +6 more
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai Jiao Tong University School of Medicin
Jun 3, 2023
Advanced Melanoma Trial in Worldwide (IMC-F106C, Nivolumab, Nivolumab + Relatlimab)
Not yet recruiting
- Advanced Melanoma
- IMC-F106C
- +2 more
-
La Jolla, California
- +61 more
Oct 31, 2023
Chronic Lymphocytic Leukemia Trial (Acalabrutinib, Obinutuzumab)
Not yet recruiting
- Chronic Lymphocytic Leukemia
- (no location specified)
Jul 10, 2023
Follicular Lymphoma Stage II, Follicular Lymphoma Stage III, Follicular Lymphoma Stage IV Trial in Australia (BMS-986369,
Not yet recruiting
- Follicular Lymphoma Stage II
- +2 more
- BMS-986369
- +2 more
-
Ballarat, Victoria, Australia
- +4 more
Mar 15, 2023
Follicular Lymphoma Trial in Italy (Radiotherapy, Radiotherapy plus Obinotuzumab)
Not yet recruiting
- Follicular Lymphoma
- Radiotherapy
- Radiotherapy plus Obinotuzumab
-
Alessandria, Italy
- +47 more
Jun 26, 2023
Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)
Not yet recruiting
- Acute Myeloid Leukemia
- Mitoxantrone hydrochloride liposome injection
- +3 more
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Jul 1, 2023
Analyzing Engagement Trends in Rhabdomyosarcoma Clinical Trials
Not yet recruiting
- Rhabdomyosarcoma
-
San Francisco, CaliforniaPower Life Sciences
Sep 1, 2023
Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)
Not yet recruiting
- Acute Myeloid Leukemia
- Mitoxantrone hydrochloride liposome injection
- +3 more
- (no location specified)
May 29, 2023
Non Hodgkin Lymphoma Trial in United Kingdom (R-CHOP + acalabrutinib)
Active, not recruiting
- Non Hodgkin Lymphoma
- R-CHOP + acalabrutinib
-
Southampton, Hampshire, United Kingdom
- +6 more
Oct 26, 2022
Pancreatic Cancer Metastatic, Pancreatic Adenocarcinoma Metastatic Trial in Scottsdale (Botensilimab, Balstilimab, Chloroquine
Not yet recruiting
- Pancreatic Cancer Metastatic
- Pancreatic Adenocarcinoma Metastatic
- Botensilimab
- +3 more
-
Scottsdale, ArizonaClinical Trials Nurse Navigator
Oct 3, 2023
Untreated Advanced or Recurrent Thymic Carcinomas Trial in Chuo (MK-3475, Lenvatinib, Carboplatin)
Not yet recruiting
- Untreated Advanced or Recurrent Thymic Carcinomas
- MK-3475
- +3 more
-
Chuo, Tokyo, JapanNational Cancer Center Hospital
Apr 16, 2023
Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Trial in Worldwide (Acalabrutinib, Venetoclax, Obinutuzumab)
Recruiting
- Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Acalabrutinib
- +2 more
-
Tucson, Arizona
- +40 more
Dec 20, 2022
High Grade MDS Trial in Aurora (Omacetaxine, Azacitidine)
Recruiting
- High Grade Myelodysplastic Syndromes
-
Aurora, ColoradoUniverstiy of Colorado Denver
Nov 17, 2022
Esophageal Squamous Cell Carcinoma Trial (LY01015, Fluorouracil, Cisplatin)
Not yet recruiting
- Esophageal Squamous Cell Carcinoma
- LY01015
- +3 more
- (no location specified)
Aug 28, 2023
Familial Investigations of Childhood Cancer Predisposition
Recruiting
- Acute Leukemia
- +45 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
May 11, 2022
Large B-Cell Lymphoma Trial in Xi'an (Glofitamab, Polatuzumab vedotin, Rituximab)
Not yet recruiting
- Large B-Cell Lymphoma
- Glofitamab
- +5 more
-
Xi'an, ChinaFirst Affiliated Hospital of Medical College of Xi'an Jiaotong U
Sep 14, 2023